Guangdong Kingshine Electronic Technology (300903.SZ) plans to launch a 2026 restricted stock incentive plan.
Kingshine Electronic Technology (300903.SZ) has released the draft of its 2026 restricted stock incentive plan, proposing to grant 7.89 million restricted shares, accounting for approximately 1.81% of the company's total share capital at the time of the announcement of the draft incentive plan. This grant is a one-time grant with no reserved rights. The grant price is RMB 55.60 per share.
Guangdong Kingshine Electronic Technology (300903.SZ) released the 2026 restricted stock incentive plan (draft), proposing to grant 7.89 million restricted shares, accounting for approximately 1.81% of the company's total share capital at the time of the announcement of the incentive plan draft. This grant is a one-time grant with no reserved rights. The grant price is 55.60 yuan per share.
The effective period of this incentive plan shall be from the date of grant of the restricted shares until the date when all restricted shares granted to the incentive recipients are vested or become invalid, with a maximum duration of no more than 60 months.
Related Articles

BlackRock reduces its holdings of CNBM (03323) by 16.392 million shares at an average price of approximately HK$3.44 per share.

FIDELITY FUNDS increases its shareholding in MEDLIVE (02192) by 1.017 million shares at approximately HK$6.81 per share.

JPMorgan increases its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.02 per share.
BlackRock reduces its holdings of CNBM (03323) by 16.392 million shares at an average price of approximately HK$3.44 per share.

FIDELITY FUNDS increases its shareholding in MEDLIVE (02192) by 1.017 million shares at approximately HK$6.81 per share.

JPMorgan increases its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.02 per share.

RECOMMEND





